Parkside Investments LLC Has $2.41 Million Stock Holdings in Enovix Corporation $ENVX

Parkside Investments LLC boosted its holdings in shares of Enovix Corporation (NASDAQ:ENVX) by 2.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 233,390 shares of the company’s stock after buying an additional 5,740 shares during the period. Parkside Investments LLC’s holdings in Enovix were worth $2,413,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of ENVX. tru Independence LLC boosted its stake in shares of Enovix by 0.4% during the 2nd quarter. tru Independence LLC now owns 295,690 shares of the company’s stock worth $3,057,000 after acquiring an additional 1,155 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Enovix by 6.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 21,413 shares of the company’s stock valued at $233,000 after purchasing an additional 1,336 shares during the period. DDD Partners LLC raised its holdings in Enovix by 5.9% in the 1st quarter. DDD Partners LLC now owns 31,461 shares of the company’s stock valued at $231,000 after acquiring an additional 1,764 shares in the last quarter. Harbor Investment Advisory LLC raised its holdings in Enovix by 6.7% in the 1st quarter. Harbor Investment Advisory LLC now owns 30,984 shares of the company’s stock valued at $227,000 after acquiring an additional 1,949 shares in the last quarter. Finally, Sava Infond d.o.o. raised its holdings in Enovix by 50.0% in the 1st quarter. Sava Infond d.o.o. now owns 6,000 shares of the company’s stock valued at $44,000 after acquiring an additional 2,000 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Stock Down 1.2%

NASDAQ:ENVX opened at $9.97 on Tuesday. The firm has a market capitalization of $1.96 billion, a P/E ratio of -11.87 and a beta of 2.08. Enovix Corporation has a 12-month low of $5.27 and a 12-month high of $16.49. The company has a quick ratio of 4.11, a current ratio of 4.37 and a debt-to-equity ratio of 0.82. The stock’s fifty day simple moving average is $10.70 and its 200-day simple moving average is $9.25.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings data on Thursday, July 31st. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 73.88% and a negative net margin of 481.35%.The business had revenue of $7.50 million for the quarter, compared to the consensus estimate of $5.48 million. During the same quarter last year, the business posted ($0.14) EPS. The firm’s revenue was up 98.2% compared to the same quarter last year. Enovix has set its Q3 2025 guidance at -0.180–0.140 EPS. Equities research analysts expect that Enovix Corporation will post -1.01 earnings per share for the current year.

Enovix announced that its board has initiated a share repurchase plan on Wednesday, July 2nd that authorizes the company to repurchase $60.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 3.1% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several research firms have commented on ENVX. Craig Hallum reaffirmed a “buy” rating and issued a $15.00 price target (up previously from $12.00) on shares of Enovix in a report on Tuesday, July 8th. TD Cowen raised Enovix to a “hold” rating and increased their target price for the stock from $7.00 to $15.00 in a report on Monday, July 7th. B. Riley reissued a “buy” rating and issued a $17.00 target price (up from $12.00) on shares of Enovix in a report on Thursday, July 10th. Cowen reissued a “hold” rating on shares of Enovix in a report on Tuesday, July 8th. Finally, Canaccord Genuity Group increased their price target on Enovix from $20.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Enovix has an average rating of “Moderate Buy” and a consensus price target of $17.00.

Enovix Company Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.